Delivery Order SPE2DR25D3505-SPE2DR26F97E2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,671.55 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,633.77 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) on November 14, 2025, with an ultimate completion date of November 17, 2025. The contract employs firm fixed price terms and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $4,506.84 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) on January 15, 2026, with an ultimate completion date of January 16, 2026. This competitive award, made without set-aside designation, was performed at the contractor's facility in Conshohocken, Pennsylvania. The contract reflects a firm fixed-price arrangement for pharmaceutical delivery under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.18 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count) on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $18,983.19 to supply Nexium DR 40 mg capsules (90-count units) with an ultimate completion date of December 17, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Nexium DR 40 mg capsules (90-count units) valued at $1,888.48 with a firm fixed price arrangement. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of January 5, 2026. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Nexium DR 40 mg capsules (90-count units) with a ceiling value of $1,089.16. This is a firm fixed-price delivery order with no set-aside designation, executed on a fully competitive basis. The order is scheduled for completion by January 14, 2026, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency has awarded a $1,125.04 delivery order to AmerisourceBergen Drug Corp for 90-count supplies of Nexium DR 40 mg capsules, with an ultimate completion date of October 24, 2025. This is a firm fixed price, non-set-aside contract with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexium DR 40 mg capsules (90-count) valued at $9,382.42. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item delivery under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a $3,611.97 delivery order to AmerisourceBergen Drug Corp for the supply of NEXIUM DR 20 mg capsules (30-count units) under a firm fixed price contract. This non-competitive delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F97E2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,089.16 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) with a completion date of January 16, 2026. This non-set-aside, firm fixed-price delivery order was awarded competitively on January 15, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of prescription medications, generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, with task orders ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/14/26 |